State of Wisconsin Investment Board’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-56,767
Closed -$295K 2387
2024
Q3
$295K Hold
56,767
﹤0.01% 2048
2024
Q2
$146K Sell
56,767
-12,305
-18% -$31.6K ﹤0.01% 2185
2024
Q1
$340K Sell
69,072
-38,346
-36% -$189K ﹤0.01% 1915
2023
Q4
$944K Buy
107,418
+29,386
+38% +$258K ﹤0.01% 1403
2023
Q3
$895K Sell
78,032
-15,146
-16% -$174K ﹤0.01% 1431
2023
Q2
$2.36M Buy
93,178
+19,962
+27% +$505K 0.01% 1246
2023
Q1
$2.36M Sell
73,216
-8,098
-10% -$261K 0.01% 1246
2022
Q4
$1.5M Buy
81,314
+9,771
+14% +$180K ﹤0.01% 1387
2022
Q3
$1.93M Sell
71,543
-1,408
-2% -$38K 0.01% 1351
2022
Q2
$1.01M Sell
72,951
-15,849
-18% -$219K ﹤0.01% 1627
2022
Q1
$1.73M Hold
88,800
﹤0.01% 1533
2021
Q4
$1.45M Hold
88,800
﹤0.01% 1345
2021
Q3
$2.47M Hold
88,800
0.01% 1230
2021
Q2
$2.63M Hold
88,800
0.01% 1222
2021
Q1
$2.48M Sell
88,800
-11,900
-12% -$333K 0.01% 1192
2020
Q4
$2.85M Sell
100,700
-3,100
-3% -$87.9K 0.01% 1119
2020
Q3
$2.61M Buy
103,800
+10,100
+11% +$254K 0.01% 1102
2020
Q2
$2.29M Sell
93,700
-175,345
-65% -$4.28M 0.01% 1096
2020
Q1
$3.98M Buy
269,045
+21,000
+8% +$311K 0.01% 870
2019
Q4
$4.03M Buy
248,045
+111,016
+81% +$1.8M 0.01% 992
2019
Q3
$1.78M Buy
137,029
+10,700
+8% +$139K ﹤0.01% 1039
2019
Q2
$1.64M Buy
126,329
+55,029
+77% +$714K ﹤0.01% 1049
2019
Q1
$1.12M Buy
71,300
+10,100
+17% +$159K ﹤0.01% 1132
2018
Q4
$1.23M Buy
61,200
+400
+0.7% +$8.05K ﹤0.01% 1073
2018
Q3
$1.51M Buy
60,800
+27,400
+82% +$681K ﹤0.01% 1092
2018
Q2
$917K Buy
33,400
+15,400
+86% +$423K ﹤0.01% 1195
2018
Q1
$554K Hold
18,000
﹤0.01% 1276
2017
Q4
$643K Hold
18,000
﹤0.01% 1241
2017
Q3
$496K Hold
18,000
﹤0.01% 1298
2017
Q2
$475K Buy
+18,000
New +$475K ﹤0.01% 1295